Skip to content

908 Devices MASS Free cash flow margin

Free cash flow margin at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
15.7%-2.1pp
WAT
Waters CorporationWAT
7%-13.8pp
Agilent Technologies logo
Agilent TechnologiesA
15%-2.9pp
Bruker logo
BrukerBRKR
1.5%-3.6pp
Mettler-Toledo International, Inc. logo
Mettler-Toledo International, Inc.MTD
19.4%-3.3pp
Danaher logo
DanaherDHR
21.4%+0.8pp

Other financials

Income statement

See full
Revenue$13.4M+13.6%
Gross profit$6.9M+24.2%
Operating income-$12.9M-16.9%
Net income-$12.0M-127%
EPS (diluted)-$0.32-126%

Balance sheet

See full
Cash & equivalents$67.6M-14.7%
Total debt$4.5M+18.6%
Total equity$134.2M-15.8%
Total assets$186.7M-4.8%

Cash flow

See full
Operating cash flow$1.2M+108%
CapEx$40.0K-74.8%
Free cash flow$1.2M+108%

Valuation

See full
Market cap$339.57M+29.0%
Enterprise value$276.47M+47.2%
P/S5.9×+0.8×

Profitability

See full
Gross margin51.5%+1.3pp
Operating margin-76.8%-19.6pp
Net margin-62.4%+323pp

Returns & leverage

See full
Return on equity-24.6%-149pp
Debt / equity0.0×
Current ratio3.6×-4.0×

Where this comes from

Calculated from 908 Devices’s reported figures.

Based on trailing twelve months.

The official record: 908 Devices’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about 908 Devices's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 908 Devices's free cash flow margin?
908 Devices (MASS) reported free cash flow margin of -16.7% in Q1 2026.
How has 908 Devices's free cash flow margin changed year-over-year?
908 Devices's free cash flow margin increased by 75.7% year-over-year, from -68.6% to -16.7%.
What is the long-term trend for 908 Devices's free cash flow margin?
Over 5 years (2020 to 2025), 908 Devices's free cash flow margin has grown at a 24.7% compound annual growth rate (CAGR), from 15.3% to -46.2%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.